FindMyKOL
Clinical trialNCT00383318CompletedObservational

Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia

NCT00383318 is an observational study sponsored by Pediatrix. As of 18 Nov 2026, it is completed. It studies Hyperbilirubinemia and Jaundice. The registry lists an enrollment of 450 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2006 and a primary completion date of 31 Dec 2007.

SponsorPediatrixEnrollment450HyperbilirubinemiaJaundice
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00383318
FieldValue
Registry IDNCT00383318
StatusCompleted
Study typeObservational study
Lead sponsorPediatrix
Enrollment450
Registered sites1
Countries1
ConditionsHyperbilirubinemia and Jaundice
Start30 Sept 2006
Primary completion31 Dec 2007
Study completion31 Dec 2007
Last update posted28 Jan 2008

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Carolina, United States1 site
  • Greenville Medical Center

    Greenville

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth Carolina: 1 siteSC1New MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00383318

Each answer restates registry values shown on this page.

What is NCT00383318?

NCT00383318 is an observational study sponsored by Pediatrix. It studies Hyperbilirubinemia and Jaundice.

Who leads NCT00383318?

The registry names Jon Watchko, MD (principal investigator, University of Pittsburgh), Reese H Clark, MD (principal investigator, Pediatrix) and Zhili Lin, PhD, MD (principal investigator, Pediatrix Screening) as overall officials.

Where does NCT00383318 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT00383318 end?

The registry lists a primary completion date of 31 Dec 2007 and a study completion date of 31 Dec 2007. The sponsor last updated the record on 28 Jan 2008.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.